Inovio Pharmaceuticals Inc vs IAC/Interactivecorp — how do they compare? Inovio Pharmaceuticals Inc trades at $1.09 (market cap $89.27M), while IAC/Interactivecorp trades at $44.3 (market cap $3.32B). The key difference: IAC/Interactivecorp is far larger — about 37.2× Inovio Pharmaceuticals Inc's market cap, and IAC/Interactivecorp is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | PPLI | |
|---|---|---|
Market Cap | $89.27M | $3.32B |
Sector | Health | Media |
52-Week High | $2.87 | $47.62 |
52-Week Low | $1.05 | $31.52 |
Enterprise Value | $60.28M | $3.63B |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →